Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22566814 | 0.93 | KMT2A (0.46) | CA9CA12CA1POLBPTGES | |
| SCHEMBL10000527 | 0.92 | MEN1 (0.46) | CA9CA12CA1POLBPTGES | |
| SCHEMBL84252 | 0.89 | MEN1 (0.42) | CA9CA12CA1POLBPTGES | |
| SCHEMBL29308184 | 0.89 | ALDH1A1 (0.52) | CA9CA12CA1POLBPTGES | |
| SCHEMBL29308141 | 0.88 | BRD4 (0.56) | CA9CA12CA1POLBPTGES | |
| SCHEMBL84265 | 0.87 | KMT2A (0.41) | CA9CA12CA1POLBPTGES | |
| SCHEMBL22627210 | 0.86 | PTGES (0.49) | CA9CA12CA1POLBPTGES | |
| SCHEMBL10000520 | 0.85 | MEN1 (0.52) | CA9CA12CA1POLBPTGES | |
| SCHEMBL14114060 | 0.84 | MEN1 (0.48) | CA9CA1POLBPKMMEN1 | |
| SCHEMBL14259658 | 0.83 | MEN1 (0.50) | CA9CA12CA1POLBPTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037319-B2 | Curable compound | DAICEL CORPORATION (JP) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037319-B2 | Curable compound | CCT5, PGA5, KDM5B | CA9 552/4885CA12 1562/4885CA1 2678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.